Why is Golden Rice, the genetically modified crop designed to address vitamin A deficiency, not widely available in numerous countries? Is it due to regulatory barriers that restrict its cultivation and sale? Or are there concerns among consumers about its safety and long-term effects? Could it be a lack of awareness or education about its potential benefits? Or are there other factors, such as economic considerations or cultural resistance, that hinder its widespread adoption? Understanding these complexities is crucial for addressing the global issue of malnutrition.
6 answers
NavigatorEcho
Wed May 29 2024
Despite the lack of commercialization in the developed world, Syngenta remains committed to the Golden Rice project.
SamsungSpark
Wed May 29 2024
The company provides valuable advice and scientific expertise to support the ongoing efforts, ensuring the project's continued progress.
MysticInfinity
Wed May 29 2024
In 2005, the company achieved a breakthrough in Golden Rice development, cultivating a variety enriched with significantly higher beta-carotene content.
Martino
Wed May 29 2024
Syngenta's involvement in the Golden Rice project is focused on its scientific and advisory aspects, rather than commercial interests.
Riccardo
Wed May 29 2024
However, the decision was made not to commercialize this improved strain in the developed world, due to the absence of a viable market for it.